Discontinued — last reported Q4 '25
Other Non-Current Liabilities
Non-Current LiabilitiesEli Lilly Other Non-Current Liabilities increased by 5.1% to $3.97B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 82.3%, from $2.18B to $3.97B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 18.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
Significant changes in this line item often require footnote disclosure to understand if they represent legal risks or specialized financial commitments.
Detailed definition
A catch-all category for long-term obligations that do not fall into specific major categories like debt or leases. This...
Peer comparison
Varies widely by company based on their specific legal, tax, and employee benefit structures.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.80B | $1.75B | $1.64B | $1.71B | $1.78B | $1.85B | $1.74B | $1.82B | $1.95B | $1.91B | $2.24B | $2.27B | $2.47B | $2.24B | $2.18B | $2.29B | $2.34B | $3.78B | $3.97B |
| QoQ Change | — | -3.0% | -6.0% | +4.2% | +4.0% | +3.9% | -6.3% | +4.9% | +7.1% | -2.3% | +17.5% | +1.3% | +8.8% | -9.4% | -2.7% | +5.1% | +2.5% | +61.1% | +5.1% |
| YoY Change | — | — | — | — | -1.0% | +6.0% | +5.6% | +6.3% | +9.5% | +2.9% | +29.0% | +24.6% | +26.6% | +17.5% | -2.8% | +0.8% | -5.1% | +68.6% | +82.3% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other non-current liabilities?
- Eli Lilly (LLY) reported other non-current liabilities of $3.97B in Q4 2025.
- How has Eli Lilly's other non-current liabilities changed year-over-year?
- Eli Lilly's other non-current liabilities increased by 82.3% year-over-year, from $2.18B to $3.97B.
- What is the long-term trend for Eli Lilly's other non-current liabilities?
- Over 5 years (2020 to 2025), Eli Lilly's other non-current liabilities has grown at a 18.4% compound annual growth rate (CAGR), from $1.71B to $3.97B.
- What does other non-current liabilities mean?
- Miscellaneous long-term debts and obligations that don't fit into other specific categories.